Your browser doesn't support javascript.
loading
The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients.
Choi, M Y; Clarke, A E; St Pierre, Y; Hanly, J G; Urowitz, M B; Romero-Diaz, J; Gordon, C; Bae, S-C; Bernatsky, S; Wallace, D J; Merrill, J T; Isenberg, D A; Rahman, A; Ginzler, E M; Petri, M; Bruce, I N; Dooley, M A; Fortin, P; Gladman, D D; Sanchez-Guerrero, J; Steinsson, K; Ramsey-Goldman, R; Khamashta, M A; Aranow, C; Alarcón, G S; Manzi, S; Nived, O; Zoma, A A; van Vollenhoven, R F; Ramos-Casals, M; Ruiz-Irastorza, G; Lim, S S; Kalunian, K C; Inanc, M; Kamen, D L; Peschken, C A; Jacobsen, S; Askanase, A; Buyon, J; Mahler, M; Fritzler, M J.
Affiliation
  • Choi MY; 1 University of Calgary, Cumming School of Medicine.
  • Clarke AE; 1 University of Calgary, Cumming School of Medicine.
  • St Pierre Y; 2 Research Institute of the McGill University Health Centre.
  • Hanly JG; 3 Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada.
  • Urowitz MB; 4 Lupus Program, Centre for Prognosis Studies in The Rheumatic Disease and Krembil Research Institute, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Romero-Diaz J; 5 Instituto Nacional de CienciasMédicas y Nutrición, Mexico City, Mexico.
  • Gordon C; 6 Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Bae SC; 7 Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea.
  • Bernatsky S; 8 Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre.
  • Wallace DJ; 9 Cedars-Sinai/David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Merrill JT; 10 Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
  • Isenberg DA; 11 Centre for Rheumatology, Department of Medicine, University College London, UK.
  • Rahman A; 11 Centre for Rheumatology, Department of Medicine, University College London, UK.
  • Ginzler EM; 12 Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, USA.
  • Petri M; 13 Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Bruce IN; 14 Arthritis Research UKCentre for Epidemiology, Centre for Musculoskeletal Research, The University of Manchester; and NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre; Manchester, UK.
  • Dooley MA; 15 Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, USA.
  • Fortin P; 16 Division of Rheumatology, Centre Hospitalier Universitaire de Québec et Université Laval, Québec City, Canada.
  • Gladman DD; 4 Lupus Program, Centre for Prognosis Studies in The Rheumatic Disease and Krembil Research Institute, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Sanchez-Guerrero J; 17 Mount Sinai Hospital and University Health Network, University of Toronto, Canada.
  • Steinsson K; 18 Center for Rheumatology Research, Landspitali University hospital, Reykjavik, Iceland.
  • Ramsey-Goldman R; 19 Northwestern University and Feinberg School of Medicine, Chicago, IL, USA.
  • Khamashta MA; 20 Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, King's College London School of Medicine, UK, London, UK.
  • Aranow C; 21 Feinstein Institute for Medical Research, Manhasset, NY, USA.
  • Alarcón GS; 22 Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Manzi S; 23 Allegheny Health Network, Pittsburgh Pennsylvania.
  • Nived O; 24 Department of Rheumatology, University Hospital Lund, Lund, Sweden.
  • Zoma AA; 25 Lanarkshire Centre for Rheumatology, Hairmyres Hospital, East Kilbride, Scotland UK.
  • van Vollenhoven RF; 26 Unit for Clinical Therapy Research (ClinTRID), Karolinska Institute, Stockholm, Sweden.
  • Ramos-Casals M; 27 Josep Font Autoimmune Diseases Laboratory, IDIBAPS, Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain.
  • Ruiz-Irastorza G; 28 Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain.
  • Lim SS; 29 Emory University School of Medicine, Division of Rheumatology, Atlanta, Georgia, USA.
  • Kalunian KC; 30 UCSD School of Medicine, La Jolla, CA, USA.
  • Inanc M; 31 Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.
  • Kamen DL; 32 Medical University of South Carolina, Charleston, South Carolina, USA.
  • Peschken CA; 33 University of Manitoba, Winnipeg, Manitoba, Canada.
  • Jacobsen S; 34 Department of Rheumatology, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, Denmark.
  • Askanase A; 35 Hospital for Joint Diseases, NYU, Seligman Centre for Advanced Therapeutics, New York NY.
  • Buyon J; 36 New York School of Medicine, New York, US.
  • Mahler M; 37 Inova Diagnostics Inc., San Diego, CA, USA.
  • Fritzler MJ; 1 University of Calgary, Cumming School of Medicine.
Lupus ; 26(10): 1051-1059, 2017 Sep.
Article in En | MEDLINE | ID: mdl-28420054

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Transcription Factors / Adaptor Proteins, Signal Transducing / Beta 2-Glycoprotein I / Lupus Erythematosus, Systemic Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Lupus Journal subject: REUMATOLOGIA Year: 2017 Document type: Article Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Transcription Factors / Adaptor Proteins, Signal Transducing / Beta 2-Glycoprotein I / Lupus Erythematosus, Systemic Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Lupus Journal subject: REUMATOLOGIA Year: 2017 Document type: Article Country of publication: Reino Unido